Literature DB >> 9015577

Comorbidity of gender dysphoria and other major psychiatric diagnoses.

C M Cole1, M O'Boyle, L E Emory, W J Meyer.   

Abstract

Previous studies suggest that many transsexuals evidence an Axis I diagnosis according to the DSM-IV classification (e.g., psychoses, major affective disorder). The current study examined retrospectively the comorbidity between gender dysphoria and major psychopathology, evaluating the charts of 435 gender dysphoric individuals (318 male and 117 female). All had undergone an extensive evaluation, addressing such areas as hormonal/surgical treatment, and histories of substance abuse, mental illness, genital mutilation, and suicide attempts. In addition, a subgroup of 137 individuals completed the MMPI. Findings revealed over two thirds were undergoing hormone reassignment, suggesting a commitment to the real-life cross-gender process. One quarter had had problems with substance abuse prior to entering treatment, but less than 10% evidenced problems associated with mental illness, genital mutilation, or suicide attempts. Those completing the MMPI (93 female and 44 male) demonstrated profiles that were notably free of psychopathology (e.g., Axis I or Axis II criteria). The one scale where significant differences were observed was the Mf scale, and this held true only for the male-to-female group. Psychological profiles as measured by the MMPI were more "normal" in the desired sex than the anatomic sex. Results support the view that transsexualism is usually an isolated diagnosis and not part of any general psychopathological disorder.

Entities:  

Mesh:

Year:  1997        PMID: 9015577     DOI: 10.1023/a:1024517302481

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  14 in total

1.  A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States.

Authors:  Sarah E Valentine; Jillian C Shipherd
Journal:  Clin Psychol Rev       Date:  2018-03-28

Review 2.  Severe Mental Illness in LGBT Populations: A Scoping Review.

Authors:  Sean A Kidd; Meg Howison; Merrick Pilling; Lori E Ross; Kwame McKenzie
Journal:  Psychiatr Serv       Date:  2016-02-29       Impact factor: 3.084

3.  Prevalence of Axis II disorders in a sample of clients undertaking psychiatric evaluation for sex reassignment surgery.

Authors:  Fabio Madeddu; Antonio Prunas; Diamante Hartmann
Journal:  Psychiatr Q       Date:  2009-12

4.  Personality disorders in persons with gender identity disorder.

Authors:  Dragana Duišin; Borjanka Batinić; Jasmina Barišić; Miroslav L Djordjevic; Svetlana Vujović; Marta Bizic
Journal:  ScientificWorldJournal       Date:  2014-05-13

5.  Assessment of self-perception of transsexual persons: pilot study of 15 patients.

Authors:  Jasmina Barišić; Marija Milosavljević; Dragana Duišin; Borjanka Batinić; Svetlana Vujović; Srdjan Milovanović
Journal:  ScientificWorldJournal       Date:  2014-04-14

6.  Psychiatric Axis I Comorbidities among Patients with Gender Dysphoria.

Authors:  Azadeh Mazaheri Meybodi; Ahmad Hajebi; Atefeh Ghanbari Jolfaei
Journal:  Psychiatry J       Date:  2014-08-11

Review 7.  Gender identity disorder and schizophrenia: neurodevelopmental disorders with common causal mechanisms?

Authors:  Ravi Philip Rajkumar
Journal:  Schizophr Res Treatment       Date:  2014-12-04

8.  Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.

Authors:  Hiroyuki Oda; Toshihiko Kinoshita
Journal:  BMC Psychiatry       Date:  2017-07-17       Impact factor: 3.630

9.  MMPI-2 Profile of French Transsexuals: The Role of Sociodemographic and Clinical Factors. A cross-sectional design.

Authors:  Mireille Bonierbale; Karine Baumstarck; Aurélie Maquigneau; Audrey Gorin-Lazard; Laurent Boyer; Anderson Loundou; Pascal Auquier; Christophe Lançon
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

10.  Comparison of Masculine and Feminine Gender Roles in Iranian Patients with Gender Identity Disorder.

Authors:  Kaveh Alavi; Mehrdad Eftekhar; Amir Hossein Jalali Nadoushan
Journal:  Sex Med       Date:  2015-09-17       Impact factor: 2.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.